Navigation Links
Cell Biosciences Announces New Leadership
Date:6/25/2008

PALO ALTO, Calif., June 25 /PRNewswire/ -- Cell Biosciences, Inc., a provider of ultrasensitive protein detection and characterization systems to life science researchers, today announced three important additions to its management team.

Tim Harkness was named President and Chief Executive Officer. From 1998 through 2007, Mr. Harkness was the Chief Financial Officer for Molecular Devices Corporation where he helped build the company into a global leader in life science research tools with over $185 million in revenue before successfully selling the company in 2007. Mr. Harkness brings deep knowledge of worldwide life sciences markets, and is expected to lead the transformation of Cell Biosciences into a mature commercial operation.

Richard Lussier was named Vice President, Sales and International Operations. Mr. Lussier has more than 20 years experience in life science sales and commercial operations, including 13 years in the Applera businesses Applied Biosystems and Celera Genomics. During his tenure at Applera, he served as President and General Manager of their Japanese subsidiary for five years. More recently, Mr. Lussier established the worldwide sales, service, and support organization for Solexa Inc., now part of Illumina Inc.

Also announced was the appointment of Walter Ausserer, Ph.D. as Vice President, Marketing. Dr. Ausserer has more than 15 years experience in the development, sales, and marketing of bioanalytical instrumentation. Most recently, he directed product development at Axela Biosensors, a developer of label-free protein characterization systems. Dr. Ausserer previously held senior product development and marketing positions at Caliper Life Sciences and Dionex Corporation.

"The Cell Biosciences team has developed a truly revolutionary technology for protein characterization that I believe has the potential to significantly impact many areas of biological research," said Mr. Harkness. "I am impressed by the tremendous potential of the Cell Biosciences team and technology, and am very excited about the opportunity to lead the company."

The management team appointments come on the heels of multiple recent placements of the Firefly(TM) 3000 system, Cell Bioscience's flagship product for ultrasensitive detection and characterization of proteins in extremely small biological samples. Cell Biosciences began accepting orders for the Firefly 3000 system in late 2007 as part of an early technology access program for leading cell signaling and translational medicine researchers. Participants in the program receive early access to the Firefly 3000 system, which provides unprecedented levels of sensitivity for the analysis of precious samples, such as tissue biopsies, fine-needle tumor aspirates, and stem cells.

To fuel its commercial expansion, the company closed a Series B financing round of $27 million in late 2006, with participation from the Wellcome Trust, Domain Associates, Latterell Venture Partners, Novo Ventures, Posco BioVentures, Mitsui & Co. Venture Partners, RBC Capital Partners and The Vertical Group.

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nano-proteomics. We are developing instrumentation systems to enable the detection of specific proteins in extremely small biological samples. The company's lead product, the Firefly 3000, is a capillary-based nanofluidic immunoassay platform designed for ultrasensitive detection and characterization of proteins. Cell Biosciences is located in Palo Alto, CA. http://www.cellbiosciences.com

For additional information, please contact Walter Ausserer, Vice President, Marketing, Cell Biosciences, Inc. 650 859-1485.


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL
2. LI-COR(R) Biosciences Introduces New Tools for High Throughput Western Blotting
3. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
4. LI-COR Biosciences Introduces Near-Infrared Small Animal Imager
5. Craig Johnson Joins Ardea Biosciences Board of Directors
6. Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
7. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
8. LI-COR(R) Biosciences and Tiger Woods Learning Center Collaborate to Develop High School Curriculum in Genetics
9. YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING
10. Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
11. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... Parallel6™ ... clinical trials worldwide, announced today that they were named one of the 2017 ... covers the latest developments in the pharmaceutical industry. , “We take pride in honoring ...
(Date:4/20/2017)... Israel , April 20, 2017  BrainStorm Cell Therapeutics ... technologies for neurodegenerative diseases, announced today that Chaim Lebovits ... Regenerative Medicine,s (ARM) 5 th Annual Cell & Gene ... EDT in Boston . In ... Officer & Chief Operating Officer, will participate in a panel ...
(Date:4/19/2017)... Yorba Linda, Ca (PRWEB) , ... April 18, 2017 , ... ... highlight new technological advances. This webinar, which is part of the Protein and ... NxT Flow Cytometer and outline where this technology fits in current and future applications. ...
(Date:4/19/2017)... (PRWEB) , ... April 19, 2017 , ... Nobilis ... Disorder , Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress ... registration of an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based ...
Breaking Biology Technology:
(Date:3/22/2017)... 21, 2017 Optimove , provider ... retailers such as 1-800-Flowers and AdoreMe, today announced ... and Replenishment. Using Optimove,s machine learning algorithms, these ... and replenishment recommendations to their customers based not ... of customer intent drawn from a complex web ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial ... ...
(Date:3/7/2017)... March 7, 2017 Brandwatch , the leading social ... The Prince,s Trust to uncover insights to support its reporting, ... The UK,s leading youth charity will be using Brandwatch ... and get a better understanding of the topics and issues that ... ...
Breaking Biology News(10 mins):